BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug discovery and development company, announced today that William H. Koster, CEO, will present a Company overview at the Natixis Bleichroeder Hidden Gems Investor Conference on Monday, October 8 at 1:45 p.m. ET.
